Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Genetic Engineering of Hematopoietic Progenitor Stem Cells for Targeted IFN-α Immunotherapy Reprogramming the Solid Tumor Microenvironment: A First-in-Man Study in Glioblastoma Multiforme (NCT03866109)

Blood (2023) 142 (Supplement 1): 4850.

https://doi.org/10.1182/blood-2023-178212

Published: 2023

Journal Articles

Reprogramming Macrophages Using Autologous Hematopoietic Stem Cells As Immunotherapy for Glioblastoma: TEM-GBM Study (NCT03866109)

Blood (2022) 140 (Supplement 1): 4575–4576.

https://doi.org/10.1182/blood-2022-165975

Published: 2022

Journal Articles

TEM-GBM: An Open-Label, Phase I/IIa Dose-Escalation Study Evaluating the Safety and Efficacy of Genetically Modified Tie-2 Expressing Monocytes to Deliver IFN-α within Glioblastoma Tumor Microenvironment

Blood (2021) 138 (Supplement 1): 2844.

https://doi.org/10.1182/blood-2021-150230

Published: 2021

Journal Articles

Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Elderly Patients with Mantle Cell Lymphoma

Blood (2021) 138 (Supplement 1): 2427.

https://doi.org/10.1182/blood-2021-145421

Published: 2021

Journal Articles

Simoultaneous Home Palliative Care in Onco-Hematological Patients: An Italian Single Institution Experience

Anna Ines Gregorini, MD, Francesca Gaia Rossi, MD, Sara Lodi Rizzini, MD, Valeria Ferla, MD, Giorgia Saporiti, MD, Loredana Pettine, MD, Mariarita Sciumè, MD, Fabio Serpenti, MD, Veronica Mattiello, Maria Chiara Barbanti, MD, Giorgio Maggioni, Luca Baldini, MD PhD, Roberto Scarani, MD, Massimo Pizzuto, MD, Francesco Onida, MD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-142631

Published: 2020

Journal Articles

Total Skin Electron Beam Therapy in Patients with Advanced Cutaneous T Cell Lymphoma Undergoing Allogeneic Stem Cell Transplantation: A Single Centre Experience

Viviana Beatrice Valli, MD, Filippo Grillo Ruggieri, MD, Giorgia Saporiti, MD, Silvia Alberti Violetti, MD, Concetta Schiavone, MD, Federica Irene Grifoni, MD, Maria Cecilia Goldaniga, MD, Francesca Casarin, Valeria Ferla, MD, Luca Baldini, MD PhD, Emilio Berti, MD, Francesco Onida, MD

Blood (2019) 134 (Supplement_1): 2042.

https://doi.org/10.1182/blood-2019-131144

Published: 2019

Journal Articles

Real-Rd - Real Life Italian Experience with Lenalidomide and Low-Dose Dexamethasone (Rd) As First Line Treatment of Newly-Diagnosed Multiple Myeloma Patients Not Eligible to Stem Cell Transplantation: Outcomes and Tolerability

Alessandra Pompa, Concetta Conticello, MD, Diana Giannarelli, PhD, Loredana Pettine, MD, Laura Paris, MD, Lucia Tognazzi, Magda Marcatti, MD, Elisabetta Antonioli, MD, Francesca Fioritoni, MD, Angela Bonalumi, MD, Silvia Mangiacavalli, Paola Bertazzoni, Iolanda Donatella Vincelli, MD, Daniele Derudas, MD, Agostina Siniscalchi, Sara Pezzatti, MD, Renato Zambello, Annalisa Citro, MD, Angelo Belotti, Alessandra Lombardo, MD, Federico Vozella, MD, Adelina Sementa, MD, Ugo Consoli, MD, Alfredo Molteni, MD, Niccolò Frungillo, MD, Massimo Gentile, MD, Gabriele Buda, MD PhD, Sara Aquino, Salvatore Palmieri, Velia Bongarzoni, MD, Alessandro Inzoli, MD, Valeria Ferla, MD, Francesca Gaia Rossi, MD, Valerio Leotta, MD, Alessandra Romano, MD PhD, Federica Elia, MD, Vittorio Del Fabro, MD, Guido Montanaro, MD, Francesca Cavallaro, MD, Monica Galli, Luca Baldini, MD PhD

Blood (2019) 134 (Supplement_1): 5555.

https://doi.org/10.1182/blood-2019-125098

Published: 2019

Journal Articles

Outpatient Stem Cell Mobilization with Low and Intermediate Dose Cyclophosphamide Is a Safe and Effective Procedure in Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplantation

Alessandra Pompa, Laura Paris, MD, Francesca Guidotti, MD, Valeria Ferla, MD, Monica Galli, MD PhD, Alessandro Rambaldi, MD Prof, Luca Baldini, Agostino Cortelezzi, Prof

Blood (2017) 130 (Supplement 1): 4476.

https://doi.org/10.1182/blood.V130.Suppl_1.4476.4476

Published: 2017

Journal Articles

Adrenal Insufficiency: An Emerging Challenge in Thalassemia?

Marta Mancarella, MD, Diletta Maira, MD, Valeria Ferla, Marco Capecchi, MD, Irene Motta, MD, Elena Cassinerio, MD, Alessia Marcon, MD, Marina Baldini, MD, Maria Domenica Cappellini, MD

Blood (2016) 128 (22): 4830.

https://doi.org/10.1182/blood.V128.22.4830.4830

Published: 2016

Journal Articles

An Observational Multicenter Study to Assess the Cost of Illness and Quality of Life in Patients with Myelodysplastic Syndromes in Italy

Valeria Santini, MD, Alessandro Sanna, MD, Alberto Bosi, MD, Giuliana Alimena, MD, Giuseppina Loglisci, MD, Alessandro Levis, MD, Flavia Salvi, MD, Carlo Finelli, MD, Cristina Clissa, MD, Giorgina Specchia, MD, Alessandra Ricco, MD, Agostino Cortelezzi, MD, Valeria Ferla, MD, Mariarita Sciumé, MD, Francesco Nobile, MD, Esther Oliva, MD, Carlo Lazzaro, EconD, Elisa Martelli, MSc

Blood (2011) 118 (21): 1023.

https://doi.org/10.1182/blood.V118.21.1023.1023

Published: 2011

NARROW

Genetic Engineering of Hematopoietic Progenitor Stem Cells for Targeted IFN-α Immunotherapy Reprogramming the Solid Tumor Microenvironment: A First-in-Man Study in Glioblastoma Multiforme (NCT03866109)

Reprogramming Macrophages Using Autologous Hematopoietic Stem Cells As Immunotherapy for Glioblastoma: TEM-GBM Study (NCT03866109)

TEM-GBM: An Open-Label, Phase I/IIa Dose-Escalation Study Evaluating the Safety and Efficacy of Genetically Modified Tie-2 Expressing Monocytes to Deliver IFN-α within Glioblastoma Tumor Microenvironment

Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Elderly Patients with Mantle Cell Lymphoma

Simoultaneous Home Palliative Care in Onco-Hematological Patients: An Italian Single Institution Experience

Total Skin Electron Beam Therapy in Patients with Advanced Cutaneous T Cell Lymphoma Undergoing Allogeneic Stem Cell Transplantation: A Single Centre Experience

Real-Rd - Real Life Italian Experience with Lenalidomide and Low-Dose Dexamethasone (Rd) As First Line Treatment of Newly-Diagnosed Multiple Myeloma Patients Not Eligible to Stem Cell Transplantation: Outcomes and Tolerability

Outpatient Stem Cell Mobilization with Low and Intermediate Dose Cyclophosphamide Is a Safe and Effective Procedure in Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplantation

Adrenal Insufficiency: An Emerging Challenge in Thalassemia?

An Observational Multicenter Study to Assess the Cost of Illness and Quality of Life in Patients with Myelodysplastic Syndromes in Italy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only